Form 8-K - Current report:
SEC Accession No. 0001213900-25-020788
Filing Date
2025-03-05
Accepted
2025-03-05 17:15:08
Documents
13
Period of Report
2025-02-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023266001-8k_biomx.htm   iXBRL 8-K 23348
  Complete submission text file 0001213900-25-020788.txt   195157

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20250227.xsd EX-101.SCH 3006
3 XBRL LABEL FILE phge-20250227_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE phge-20250227_pre.xml EX-101.PRE 22353
15 EXTRACTED XBRL INSTANCE DOCUMENT ea023266001-8k_biomx_htm.xml XML 3648
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 25712389
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)